ExpertiseUpdated on 8 May 2025

Biotechnology and genomics

Chris Kozak-Lenkeit PhD

Independent consultant at KozakDx

Warsaw, Poland

About

·       Life scientist turned Product and Project Manager/Consultant with a record of adapting the latest tech.

·       Spearheaded a digital transformation with 100x increase in data volume, with 6 partner institutions.

·       Managed, queried and visualised data through complex workflows in 4 programming languages.

·       Supervised 14 MA/PhD-level reports across 3 top universities and CEE’s most profitable biotech.

·       Reviewed and advised dozens of startups, helping to award $10 million in government grants.

·       Effective speaker and writer: communicated complex insights through 22 technical reports.

Field

  • Biotech, Pharma and Cosmetics
  • Healthcare
  • Bioinformatics- more specific?

Organisation

KozakDx

Company (SME)

Warsaw, Poland

Similar opportunities

  • Project cooperation

    ACRE AI

    • Partner seeks Consortium/Coordinator
    • Consortium/Coordinator seeks Partners
    • HORIZON-HLTH-2025-01-TOOL-02: Advancing cell secretome-based therapies
    • Cluster Food (CL6): HORIZON-CL6-2025-02-FARM2FORK-12 Nutrition and Mental Health
    • HORIZON-CL4-2025-03-HUMAN-18: GenAI4EU central Hub (CSA) (AI/Data/Robotics Partnership)
    • HORIZON-HLTH-2025-03-TOOL-01-two-stage: Enhancing cell therapies with genomic techniques
    • HORIZON-HLTH-2025-01-IND-01: Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs)
    • HORIZON-CL4-2025-04-DATA-03: Software Engineering for AI and generative AI (RIA) (AI/Data/Robotics Partnership)
    • HORIZON-CL4-2025-04-DIGITAL-EMERGING-06: Challenge-Driven GenAI4EU Booster (RIA) (AI/Data/Robotics Partnership)
    • HORIZON-CL4-2025-03-DATA-13: Fostering Innovative and Compliant Data Ecosystems (IA) (AI, Data and Robotics Partnership)
    • Cluster Health (CL1): HORIZON-HLTH-2025-01-DISEASE-04: Leveraging artificial intelligence for pandemic preparedness and response
    • HORIZON-CL4-2025-04-DATA-02: Empowering AI/generative AI along the Cognitive Computing continuum (RIA) (AI/Data/Robotics Partnership)
    • HORIZON-HLTH-2025-01-IND-02: Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices
    • Cluster Health (CL1): HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage: Advancing knowledge on the impacts of micro- and nanoplastics on human health
    • Cluster Health (CL1): HORIZON-HLTH-2025-01-CARE-01: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU)
    • Cluster Health (CL1): HORIZON-HLTH-2025-03-ENVHLTH-01-two-stage: The impact of pollution on the development and progression of brain diseases and disorders
    • Cluster Health (CL1): HORIZON-HLTH-2025-03-DISEASE-02-two-stage: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders
    • Cluster Health (CL1): HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage: Improving the quality of life of persons with intellectual disabilities and their families
    • HORIZON-HLTH-2025-01-IND-03: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices
    • Cancer Mission: HORIZON-MISS-2025-02-CANCER-02: Understanding the effects of environmental exposure on the risk of paediatric, adolescent and young adult cancers
    • HORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential
    • HORIZON-HLTH-2025-01-DISEASE-01: Randomised controlled trials to test safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections
    • Cluster Health (CL1): HORIZON-HLTH-2025-01-TOOL-03: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)
    • HORIZON-HLTH-2025-03-DISEASE-06-two-stage: Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD)

    Robert Lugowski

    CEO at CliniNote

    Warsaw, Poland

  • Project cooperation

    Horizon Europe: Digital pharma marketplace for licensing & distribution

    Mariusz Wituszynski

    Investor Relations at Nubinno Connect

    Warsaw, Poland

  • Project cooperation

    Open Call & FSTP Management

    Kasia Kulikowska

    EU Projects Expert at FundingBox

    Warsaw, Poland